WHO ICTRP trial
Continuous Glucose Monitoring System in patients with Cystic Fibrosis
NL-OMON31821 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON31821 |
|---|---|
| Public title | Continuous Glucose Monitoring System in patients with Cystic Fibrosis |
| Scientific title | Continuous Glucose Monitoring System in patients with Cystic Fibrosis - CGMS in CF |
| Primary sponsor | HagaZiekenhuis |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | Cystic fibrosis and diabetes;10038686;10018424;Cystic fibrosis and diabetes |
| Interventions | ;Continuous Glucose Monitoring System;Cystic Fibrosis;Cystic Fibrosis-related diabetes |
| Registration date | Nov 24, 2008 |
| Target size | 18 |
| Secondary IDs | NL21343.098.08 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: